NuGen Medical Devices Inc.
NGMDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $35 | $22 | $117 | $416 |
| % Growth | 56.8% | -81.1% | -71.9% | – |
| Cost of Goods Sold | $14 | $9 | $52 | $191 |
| Gross Profit | $21 | $13 | $65 | $225 |
| % Margin | 60.9% | 60.2% | 55.3% | 54.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $842 | $747 | $935 |
| SG&A Expenses | $1,216 | $842 | $747 | $935 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $164 | $158 | $158 |
| Operating Expenses | $1,216 | $1,006 | $905 | $1,093 |
| Operating Income | -$1,194 | -$993 | -$840 | -$868 |
| % Margin | -3,444.4% | -4,488.1% | -718.7% | -208.8% |
| Other Income/Exp. Net | -$677 | -$1,330 | $2,410 | $1,374 |
| Pre-Tax Income | -$1,871 | -$2,323 | $1,569 | $506 |
| Tax Expense | -$5 | $4 | $4 | -$4 |
| Net Income | -$1,867 | -$2,327 | $1,566 | $510 |
| % Margin | -5,383.1% | -10,520.5% | 1,339.5% | 122.7% |
| EPS | -0.008 | -0.01 | 0.007 | 0.002 |
| % Growth | 21.6% | -247.8% | 200% | – |
| EPS Diluted | -0.008 | -0.01 | 0.007 | 0.002 |
| Weighted Avg Shares Out | 227,036 | 227,036 | 226,470 | 217,316 |
| Weighted Avg Shares Out Dil | 227,036 | 227,036 | 226,470 | 217,316 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $801 | $737 | $671 | $716 |
| Depreciation & Amortization | $170 | $164 | $158 | $158 |
| EBITDA | -$901 | -$1,422 | $2,398 | $1,380 |
| % Margin | -2,598.1% | -6,429.5% | 2,051.9% | 332% |